Regulating the level of glucose in the blood of an animal comprising the consumption by the animal of a composition containing beta casein or providing the composition to the animal for consumption where the beta casein comprises at least 75% by weight beta casein A2. Uses include managing the symptoms of hyperglycaemia and associated conditions including diabetes. The effect is both acute (post exposure to the composition) and ongoing.
